BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9432845)

  • 1. [The role of the complement system in the pathogenesis of yersinioses].
    Kudrina NV; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):41-4. PubMed ID: 9432845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune complexes and R-proteins in yersinioses].
    Besednova NN; Kudrina NV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):45-9. PubMed ID: 9432846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunological indices in pathology due to yersiniosis].
    Voskresenskaia EA; Tseneva GIa; Alenushkina TV; Skvortsov AE
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):68-73. PubMed ID: 9082734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenic properties of Yersinia and their role in yersiniosis pathology].
    Daĭter AB; Polotskiĭ IuE; Tseneva GIa
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):108-15. PubMed ID: 3554847
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of complement activity in vitro and in vivo by Yersinia wild and mutant strains.
    Yordanov M; Golkocheva E; Najdenski H
    Folia Microbiol (Praha); 2006; 51(1):27-32. PubMed ID: 16821708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of infections with Yersinia pseudotuberculosis and Yersinia enterocolitica in the pathogenesis of chronic inflammatory, rheumatic and collagen diseases.
    Georgescu C; Dan E; Cojocaru M; Plosceanu L
    Med Interne; 1986; 24(3):217-20. PubMed ID: 3534995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enteropathogenic Yersinia and host cytokine system].
    Zheleznikova GF; Bekhtereva MK
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):112-21. PubMed ID: 21384597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
    Rastawicki W
    Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The function of the body phagocytic system in yersiniosis and the possibilities for correcting its disorders].
    Shuvalova EP; Krotkova MR; Ivashchenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):82-3. PubMed ID: 8079586
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinico-allergic indices of yersiniosis patients].
    Rashidova RA; Babakhodzhaev SN; Mukhamedov IB
    Ter Arkh; 1991; 63(11):33-5. PubMed ID: 1810058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A combined outbreak of intestinal yersiniosis and pseudotuberculosis in a children's health-promotion camp].
    Solodovnikov IuP; Cherkashina RI; Generalova LI; Filatov NN; Ivanenko AV; Ivanova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):110. PubMed ID: 9532706
    [No Abstract]   [Full Text] [Related]  

  • 12. [The basic features of the pathogenesis of pseudotuberculosis (yersiniosis)].
    Avtsyn AP; Isachkova LM; Zhavoronkov AA; Somov GP; Makhnev MV
    Arkh Patol; 1990; 52(5):3-7. PubMed ID: 2204325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Yersinia enterocolitica and pseudotuberculosis reactive arthritis with antinuclear antibodies. 4 cases].
    Treves R; Arnaud M; Jacob P; Burki F; Desproges-Gotteron R
    Sem Hop; 1983 Jan; 59(2):122-3. PubMed ID: 6301030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Findings of yersiniosis in the Crimea].
    Shikulov VA; Khaĭtovich AB; Bogatyreva DM; Bandura SA; Nekrasova LI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):36-8. PubMed ID: 2683523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychrophilic properties of pathogenic microorganisms and their epidemiological and pathogenetic significance].
    Somov GP
    Vestn Akad Med Nauk SSSR; 1985; (1):58-65. PubMed ID: 3883673
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of Yersinia specific antibodies in hospitalized patients with arthritis and Reiter syndrome.
    Constantiniu S; Chiriac R; Popovici N
    Arch Roum Pathol Exp Microbiol; 1989; 48(4):341-6. PubMed ID: 2520672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects, pathogenesis and treatment of Yersinia infections].
    Iushchuk ND; Karetkina GN; Proskurina LN; Malov IV; Via'lba EV
    Klin Med (Mosk); 1989 May; 67(5):91-7. PubMed ID: 2671487
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility of wild mice to Yersinia pseudotuberculosis and Yersinia enterocolitica.
    Fukushima H
    Zentralbl Bakteriol; 1991 Oct; 275(4):530-40. PubMed ID: 1755925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diagnostic ELISA test for discrimination between infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Wielkoszynski T; Moghaddam A; Bäckman A; Broden J; Piotrowski R; Mond-Paszek R; Kozarenko A; Ny T; Wilczynska M
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2301-2306. PubMed ID: 30238343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiology of Yersinia infections in the central taiga subzone of the eastern European plain].
    Vorontsova TA; Sel'kov IuA; Shchukina TN; Iushchenko GV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):35-9. PubMed ID: 8067089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.